Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOFILCHEM Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
73 GF Score
Price ₹32.06
GF Value ₹48.09
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Biofil Chemicals & Pharmaceuticals Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:BIOFILCHEM
73GF Score
Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals stock appears to be undervalued. The current stock price of ₹32.06 is trading 33.3% below its estimated GF Value™ of ₹48.09. GuruFocus considers Biofil Chemicals & Pharmaceuticals to be Significantly Undervalued.

Key valuation signals for NSE:BIOFILCHEM:

  • Short Ratio:
  • GF Value™: ₹48.09 vs. price of ₹32.06 (33.3% below fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the NSE:BIOFILCHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biofil Chemicals & Pharmaceuticals Business Description

Other Exchanges 524396:India
Address 11/12, Sector E Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
73GF Score

Get the complete analysis for NSE:BIOFILCHEM

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹32.06
Price
₹48.09
GF Value